Encouraging Data on Use of Anabolic Agents in Patients with Osteoporosis Undergoing Spinal Fusion
In this post, Editor-in-Chief Dr. Marc Swiontkowski discusses a new study in JBJS that assesses the impact of teriparatide use …
In this post, Editor-in-Chief Dr. Marc Swiontkowski discusses a new study in JBJS that assesses the impact of teriparatide use …
Vitamin D supplementation, fracture risk, and osteoporosis drug therapies are among several topics explored in recent studies featured in the …
Recent studies on topics such as rates of lumbar spinal stenosis recurrence and the cost-effectiveness of early microdiscectomy are discussed …
A video summary is available with the new study by Parodi et al. in JBJS:Â
In this post, Dr. Thomas Bauer, Co-Editor of JBJS Case Connector, discusses a recent report of 2 cases of Mycobacterium …
Patient outcomes ≥40 years after treatment for adolescent idiopathic scoliosis, return-to-sport rates following periacetabular osteotomy, and other important findings …
Dr. Matt Schmitz, JBJS Deputy Editor for Social Media, discusses a new study evaluating curve progression after skeletal maturity in …
In a new study in JBJS, Mills et al. evaluate whether cement augmentation increases the risk of secondary fracture following …
Botulinum toxin treatment of plantar fasciitis, clinical applications of point-of-care ultrasound, and other key topics are presented in the new …